Combination of the Hypercvad Regimen with Dasatinib Is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LB).

被引：25
|
作者：
Ravandi, Farhad
Kantarjian, Hagop M.
Cortes, Jorge
Thomas, Deborah A.
Faderl, Stefan
Jones, Dan
Jabbour, Elias [1 ]
Koller, Charles
Dara, Samuel [1 ]
Garris, Rebecca
Kebriaei, Partow
Borthakur, Gautam
Ferrajoli, Alessandra
O'Brien, Susan
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.636.636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：806 / 807
页数：2
相关论文
共 50 条
  • [1] Combination of the Hypercvad Regimen with Dasatinib in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) or Lymphoid Blast Phase of Chronic Myeloid Leukemia (CML-LB)
    Liu-Dumlao, Theresa
    O'Brien, Susan
    Cortes, Jorge E.
    Thomas, Deborah A.
    Faderl, Stefan
    Jabbour, Elias
    Koller, Charles
    Garris, Rebecca
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Kantarjian, Hagop M.
    Ravandi, Farhad
    BLOOD, 2011, 118 (21) : 1106 - 1106
  • [2] Combination of the hyperCVAD Regimen with Dasatinib is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Meyloid Leukemia (CML-LB)
    Jabbour, Elias
    O'Brien, Susan
    Thomas, Deborah A.
    Faderl, Stefan
    Koller, Charles Asa
    Dara, Samuel
    Garris, Rebecca
    Cortes, Jorge
    Kantadian, Hagop M.
    Ravandi, Farhad
    BLOOD, 2008, 112 (11) : 1004 - 1004
  • [3] Phase II study of combination of the HyperCVAD regimen with dasatinib in patients with Philadelphia chromosome (Ph) or BCR-ABL positive acute lymphoblastic leukemia (ALL) and lymphoid blast phase chronic myeloid leukemia (CML-LB)
    Ravandi, Farhad
    Thomas, Deborah
    Kantarjian, Hagop
    Faderl, Stefan
    Koller, Charles
    Brown, Devri
    Garris, Rebecca
    Borthakur, Gautam
    Burger, Jan
    Kebriaei, Partow
    Jorgensen, Jeffrey
    Jones, Dan
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2007, 110 (11) : 828A - 828A
  • [4] Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia
    Benjamini, Ohad
    Dumlao, Theresa Liu
    Kantarjian, Hagop
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Faderl, Stefan
    Jorgensen, Jeffrey
    Luthra, Rajyalakshmi
    Garris, Rebecca
    Thomas, Deborah
    Kebriaei, Partow
    Champlin, Richard
    Jabbour, Elias
    Burger, Jan
    Cortes, Jorge
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (03) : 282 - 287
  • [5] Dasatinib population pharmacokinetics in patients with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (ph plus all)
    Dai, Guowei
    Roy, Amit
    Mandava, Mohan
    Blackwood-Chirchir, Anne
    Luo, Roger
    Wu, Chiyuan
    Pfister, Marc
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1085 - 1085
  • [6] Phase II Study of Combination of the Hypercvad Regimen with Dasatinib in the Front Line Therapy of Patients with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Faderl, Stefan
    Jones, Dan
    Koller, Charles A.
    Dara, Samuel
    Garris, Rebecca
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Wierda, William G.
    Burger, Jan A.
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2009, 114 (22) : 345 - 345
  • [7] Phase II Study of Combination of hyperCVAD with Dasatinib in Frontline Therapy of Patients with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
    Ravandi, Farhad
    Thomas, Deborah
    Kantarjian, Hagop
    Faderl, Stefan
    Koller, Charles
    Dara, Samuel
    Garris, Rebecca
    Kebriaei, Partow
    Borthakur, Gautam
    Wierda, William
    Burger, Jan
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2008, 112 (11) : 1005 - 1005
  • [8] Phase II study of combination of the hyperCVAD regimen with dasatinib in patients (pts) with newly diagnosed Philadelphia chromosome positive (Ph plus ) acute lymphoblastic leukemia (ALL)
    Ravandi, F.
    Faderl, S.
    Thomas, D. A.
    Brown, D.
    Garris, R.
    Borthakur, G.
    Ferrajoli, A.
    Cortes, J. E.
    Kantarjian, H. M.
    O'Brien, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Outcome of Patients with Chronic Myeloid Leukemia in Lymphoid Blast Crisis (CML-LBC) and Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Treated with Hyper-CVAD and Dasatinib
    Morita, Kiyomi
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Sasaki, Koji
    Jain, Nitin
    Konopleva, Marina
    Short, Nicholas J.
    Takahashi, Koichi
    Khouri, Rita
    Nasnas, Patrice
    DiNardo, Courtney D.
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    Daver, Naval
    Bravo, Guillermo Montalban
    Issa, Ghayas C.
    Cortes, Jorge E.
    Jabbour, Elias
    BLOOD, 2020, 136
  • [10] Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia
    Jain, Nitin
    Maiti, Abhishek
    Ravandi, Farhad
    Konopleva, Marina
    Daver, Naval
    Kadia, Tapan
    Pemmaraju, Naveen
    Short, Nicholas
    Kebriaei, Partow
    Ning, Jing
    Cortes, Jorge
    Jabbour, Elias
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (08) : 1000 - 1007
12345